NM_001118887.2:c.*3315A>C
Variant names:
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001118887.2(ANGPT2):c.*3315A>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000112 in 1,432,018 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.00016 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00011 ( 2 hom. )
Consequence
ANGPT2
NM_001118887.2 3_prime_UTR
NM_001118887.2 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.210
Publications
9 publications found
Genes affected
ANGPT2 (HGNC:485): (angiopoietin 2) This gene belongs to the angiopoietin family of growth factors. The protein encoded by this gene is an antagonist of angiopoietin 1, and both angiopoietin 1 and angiopoietin 2 are ligands for the endothelial TEK receptor tyrosine kinase. Angiopoietin 2 is upregulated in multiple inflammatory diseases and is implicated in the direct control of inflammation-related signaling pathways. The encoded protein affects angiogenesis during embryogenesis and tumorigenesis, disrupts the vascular remodeling ability of angiopoietin 1, and may induce endothelial cell apoptosis. This gene serves a prognostic biomarker for acute respiratory distress syndrome. [provided by RefSeq, Aug 2020]
MCPH1 (HGNC:6954): (microcephalin 1) This gene encodes a DNA damage response protein. The encoded protein may play a role in G2/M checkpoint arrest via maintenance of inhibitory phosphorylation of cyclin-dependent kinase 1. Mutations in this gene have been associated with primary autosomal recessive microcephaly 1 and premature chromosome condensation syndrome. Alternatively spliced transcript variants have been described. [provided by RefSeq, Feb 2010]
MCPH1 Gene-Disease associations (from GenCC):
- microcephaly 1, primary, autosomal recessiveInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- microcephaly with intellectual disabilityInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- autosomal recessive primary microcephalyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary breast carcinomaInheritance: AD Classification: LIMITED Submitted by: ClinGen
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BS2
High Homozygotes in GnomAdExome4 at 2 Unknown gene
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANGPT2 | ENST00000629816.3 | c.*3315A>C | 3_prime_UTR_variant | Exon 9 of 9 | 1 | NM_001118887.2 | ENSP00000486858.2 | |||
MCPH1 | ENST00000344683.10 | c.2137-66T>G | intron_variant | Intron 11 of 13 | 1 | NM_024596.5 | ENSP00000342924.5 |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152040Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
24
AN:
152040
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000106 AC: 136AN: 1279862Hom.: 2 Cov.: 18 AF XY: 0.000141 AC XY: 91AN XY: 646538 show subpopulations
GnomAD4 exome
AF:
AC:
136
AN:
1279862
Hom.:
Cov.:
18
AF XY:
AC XY:
91
AN XY:
646538
show subpopulations
African (AFR)
AF:
AC:
0
AN:
29748
American (AMR)
AF:
AC:
6
AN:
44466
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
24964
East Asian (EAS)
AF:
AC:
0
AN:
38782
South Asian (SAS)
AF:
AC:
73
AN:
82522
European-Finnish (FIN)
AF:
AC:
0
AN:
52414
Middle Eastern (MID)
AF:
AC:
2
AN:
3824
European-Non Finnish (NFE)
AF:
AC:
46
AN:
948952
Other (OTH)
AF:
AC:
9
AN:
54190
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
8
17
25
34
42
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.000158 AC: 24AN: 152156Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74404 show subpopulations
GnomAD4 genome
AF:
AC:
24
AN:
152156
Hom.:
Cov.:
32
AF XY:
AC XY:
16
AN XY:
74404
show subpopulations
African (AFR)
AF:
AC:
0
AN:
41546
American (AMR)
AF:
AC:
8
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3466
East Asian (EAS)
AF:
AC:
2
AN:
5178
South Asian (SAS)
AF:
AC:
7
AN:
4816
European-Finnish (FIN)
AF:
AC:
0
AN:
10576
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
7
AN:
67970
Other (OTH)
AF:
AC:
0
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.517
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.